Technology & innovation

This archive covers technology and innovation breakthroughs that improve lives, protect the environment, and expand human possibility. From medical devices to clean energy tools, the stories here focus on what’s working and who’s making it happen.

Person with alopecia, for article on alopecia areata treatment

U.S. FDA approves first alopecia drug that restores hair growth in many patients

Alopecia areata has affected roughly 7 million Americans without a single FDA-approved systemic treatment — until now. Baricitinib works by blocking the inflammatory signals that cause the immune system to attack hair follicles, giving them a chance to recover. In clinical trials, one in three patients with severe cases regrew enough hair to cover at least 80% of their scalp. Approval also unlocks insurance coverage, turning a once-inaccessible therapy into a realistic option. This breakthrough shows how a single curious clinician, one patient, and a decade of persistence can rewrite what medicine believes is possible.

Space solar transmission project, for article on space solar power

China builds world-first full-function space solar verification tower

Space solar power just cleared a milestone that researchers once thought was still years away. China’s test tower at Xidian University is the first facility anywhere to run the complete chain — concentrating sunlight, converting it to electricity, and beaming that power wirelessly to a ground receiver — all in one integrated system, completed roughly three years ahead of schedule. It’s a research milestone, not a power plant, but proving the full system works in one place gives scientists a permanent platform to push the technology forward.

Vials of blood, for article on cancer diagnostics Africa, for article on Parkinson's blood test

First-of-a-kind blood test paves way for early Parkinson’s diagnosis

A simple blood test that could catch Parkinson’s disease before symptoms take hold is now closer to reality. Researchers at Kobe University developed an assay that reads changes in enzyme activity in a blood sample, achieving 85 to 88 percent accuracy in both human and rat models. Because treatments like levodopa and exercise work better early in the disease’s progression, earlier detection could meaningfully change what’s possible for patients. With Parkinson’s cases more than doubling globally over the past 25 years, affordable, scalable screening tools like this one could reshape how the world responds to the fastest-growing neurological disorder.